MARKET CURRENTS
real-time news and commentary for investors
- Tuesday, May 24, 2011, 8:48 AM Nestle (NSRGF.PK) agrees to buy Prometheus Laboratories, a maker of treatments for cancer and gastrointestinal illnesses. Financial terms weren't disclosed, but Nestle may have paid 500M-1B Swiss francs ($567M-$1.1B) for the San Diego firm.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
